Evidence map›Paper›PMID 23549023›Full record

ArticleHuman antibodies2012

Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramer.

Liuzhe Li, Xiao-Hong Wang, Sagarika Banerjee, Barbara Volsky, Constance Williams, M Anthony Moody, Susan Zolla-Pazner, Miroslaw K Gorny

Abstract read
In one paragraph

Article in Human antibodies, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Liuzhe LiDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Xiao-Hong Wang
Sagarika Banerjee
Barbara Volsky
Constance Williams
M Anthony Moody
Susan Zolla-Pazner
Miroslaw K Gorny
New York University · USDuke Medical Center · USVA NY Harbor Healthcare System · US

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI HAHN, BEATRICE H · 2006 to 2011
$290.5M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO HIV1R01HL059725 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZOLLA-PAZNER, SUSAN B · 1997 to 2014
$8.8M
Production of Cross-Neutralizing HIV-1 Antibodies from Single B CellsR56AI091543 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GORNY, MIROSLAW K · 2011 to 2014
$934k
Induction of HIV Neutralizing Antibodies by Targeting Macaque B Cell ReceptorsR21AI096977 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GORNY, MIROSLAW K · 2012 to 2014
$579k
NHLBI NIH HHS HL59725NHLBI NIH HHS R01 HL059725NIAID NIH HHS AI067854NIAID NIH HHS AI091543NIAID NIH HHS AI096977NIAID NIH HHS R21 AI096977NIAID NIH HHS R56 AI091543NIAID NIH HHS U01 AI067854NIAID NIH HHS U19 AI067854
6 · The paper itself

Abstract

The production of human monoclonal antibodies (mAbs) has been improved recently using the single B cell and PCR technology. A number of new anti-HIV-1 mAbs directed to various epitopes were produced by selecting single B cells from HIV positive individuals using the HIV-1 envelope (Env) proteins, and we tested whether the peptide can select B cells specific to a particular Env epitope. Using the fluorescently-labeled peptide tetramer representative of the V3 loop of HIV-1 Env gp120 for staining the B cells derived from one HIV-1 infected donor, four clonal human mAbs were produced with specificity to the V3 region. The clonality of the four V3 mAbs was based on the usage of the same immunoglobulin genes and almost identical sequence of CDRs. The amino acid changes were present only in the framework and, possibly, they could be related to the differences observed in the relative affinity binding of these four mAbs to V3 antigen. One representative V3 mAb displayed very potent neutralizing activity to one of two viruses tested. This study shows the feasibility of utilizing a peptide tetramer to select epitope-specific B cells and produce mAbs.

Indexed as

Amino Acid SequenceAntibodies, MonoclonalAntibody SpecificityBinding SitesB-LymphocytesCells, CulturedClone CellsEpitopesHIV-1HIV AntibodiesHIV Envelope Protein gp120HIV InfectionsHumansMolecular Sequence DataNeutralization TestsPeptidesAntibodies, MonoclonalEpitopesHIV AntibodiesHIV Envelope Protein gp120Peptides

Identifiers

PMID23549023
PMCPMC3708495
OpenAlexW19758665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.